Trial intelligence / Profile preview

Etanercept in Palmoplantar Pustulosis

NCT00353119Phase 3Completed

Sponsor
Innovaderm Research
Start
Apr 2006
Primary completion
Mar 2007
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 3 trial of etanercept in palmoplantar pustulosis (PPP), sponsored by Innovaderm Research. Started Apr 2006; status: completed.

02

Drugs

etanercept
03

Conditions

palmoplantar pustulosis (PPP)

Beyond the preview

Go deeper on NCT00353119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00353119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call